AI blood test finds silent liver disease years before symptoms

sciencedaily - Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wid…

AI Summary: Researchers unveiled an AI‑driven liquid biopsy that scans genome‑wide cell‑free DNA fragment patterns to flag liver fibrosis, cirrhosis and chronic liver disease well before symptoms appear. Early results indicate the test can identify disease signals years ahead of clinical diagnosis, offering a shot at much earlier intervention — if practice and payers cooperate.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Smartphone app improves premature ejaculation outcomes in randomized trial / 2 months

DeepRare AI beats clinicians at diagnosing rare diseases / 3 months

Grail’s Galleri blood test misses UK study goal; investor jitters / 3 months

FDA clears wearable electric-field therapy for pancreatic cancer patients / 3 months

Researchers grow liver tissue in patients' bodies; study now under scrutiny / 6 wks

CMS proposes mandatory bundled model for joint replacements nationwide / 7 wks

Privacy advocates sue CMS over Medicare AI prior-authorization pilot / 1 month